Agenda
7:45 AM – 7:50 AM Opening Remarks
Chair - Dr. Moussa Mansour
Discussants - Dr. Dhanunjaya Lakkireddy and Dr. Abdi Rasekh
7:50 AM – 8:00 AM Understanding the LAA Anatomy – Relevance to Systemic Thromboembolization and Exclusion Techniques - Dr. Luigi Di Biase
8:00 AM – 8:10 AM Pre and Intra-Procedural 2D and 3D TEE Imaging for Effective LAA Exclusion - Dr. Sreekanth Vemulaplai
8:10 AM – 8:20 AM Can CT Imaging Be A Choice Alternative for LAAO for Pre and Post Procedural Assessment? - Dr. Apostolos Tzikas
8:20 AM – 8:30 AM New Insights Into Left Atrial Appendage Role in Atrial Arrhythmia's Origin and Maintenance - Dr. Samuel Asirvatham
8:30 AM – 8:40 AM Is the Thromboembolic Risk of Rheumatic AF Different Than Non-Valvular AF and Why? Is There A Role for LAA Closure? - Dr. Anil Saxena
8:40 AM – 8:50 AM. Panel Discussion
Chair - Dr. Samuel Asirvatham
Discussants - Dr. Devi Nair and Dr. Douglas Gibson
8:50 AM – 9:00 AM Radiofrequency Ablation for Closing WATCHMAN and Lariat Leaks - Dr. Dhanunjaya Lakkireddy
9:00 AM – 9:10 AM Impact of LAA Exclusion - ANP, RAAS and LAA Homeostasis - Dr. Krysztof Bartus
9:10 AM – 9:50 AM LIVE CASE
9:50 AM – 10:00 AM How to Prevent and Manage LAAO Device Embolization - Dr. David Holmes
10:00 AM – 10:10 AM LAA Exclusion in Arrhythmia Rx - LAALA AF, Amaze and More - Dr. David Wilbur
10:10 AM – 10:35 AM Debate: Endocardial LAA Isolation With RFA Followed By An Occluder Placement A Better Strategy For Persistent AF Patients? Versus Epicardial LAA Exclusin and RFA A Better Strategy For Persistent AF Patients? - Dr. Andrea Natale/Dr. Walid Saliba
10:35 AM – 10:45 AM Economics of LAAO Program - The Organizational Perspective - Dr. Srijoy Mahapatra
Chair - Dr. Amin Al-Ahmad
Discussants - Dr. Alap Shah and Dr. Rodney Horton
10:45 AM – 10:55 AM Safe and Effective Dry Epicardial Access - Micro-Puncture, Epiep and More Practical Tips - Dr. Christopher Ellis
10:55 AM – 11:30 AM LIVE CASE
11:30 AM – 11:40 AM Best Practices Managing Post-Procedural Pericarditis & Plural Effusion – Colchicine, Steroids, Liposomal Bupivacaine and More - Dr. Rakesh Gopinathannair
11:40 AM – 11:50 AM How to Manage Acute and Sub-Acute Pericardial Effusions After LAA Closure Device Placement? - Dr. Randall Lee
11:50 PM – 12:15 PM Panel Discussion
12:15 PM – 1:00 PM Lunch Break
Chair - Dr. Oussama Wazni
Discussants - Dr. David Holmes and Dr. Aloke Finn
1:00 PM – 1:10 PM Customizing Transseptal Access & Sheath Type Based On Anatomy and Orientation of LAA - Dr. Moussa Mansour
1:10 PM – 1:50 PM LIVE CASE
1:50 PM – 2:00 PM How Do You Manage Patients With Persistent LAA Filling Defect (Thrombus) - More Anticoagulation or LAAO? - Dr. Jie Cheng
2:00 PM – 2:10 PM Abridged Post LAAO OAC & DAP Prescription Is As Good As the IFU Guidelines - The Mt Sinai Experience - Dr. Vivek Reddy
2:10 PM – 2:20 PM ICE is a Better Tool for Intraprocedural Management of LAA Closure Devices - Dr. Mohammed Alkhouli
2:20 PM – 2:30 PM Device Related Thrombus – Is the True Achilles Heel of LAAO? Incidence, Mechanism and Prevention - Dr. Amin Al-Ahmad
2:30 PM – 2:40 PM How to Manage DRT in Patients OAC Tolerant and Intolerant - Dr. Srinivas Dukkipati
2:40 PM – 3:00 PM Panel Discussion
3:00 PM – 3:20 PM Break
Chair - Dr. Andrea Natale
Discussants - Dr. Saibal Kar and Dr. Srikanth Vemulapalli
3:20 PM – 4:00 PM LIVE CASE
4:00 PM – 4:20 PM The John Madden Memorial Founders' Lecture - Humble Beginnings in Percutaneous LAA Closure - Dr. Horst Sievert
4:20 PM – 4:30 PM Post Implant Endothelialization - Impact On Closure and Leaks, Differences Amongst Various Techniques - Dr. Aloke Finn
4:30 PM – 4:40 PM Implications of Leaks on Systemic Thromboembolism and Long Term OAC/APT After LAA Occlusion - Dr. Amin Al-Ahmad
4:40 PM - 4:50 PM Management of Endocardial Occluder Leaks - Plugs and Coils - Dr. Rodney Horton
4:50 PM – 5:00 PM Closing Endocardial Occluder Leaks Using Radiofrequency Ablation - Dr. Dhanunjaya Lakkireddy
5:00 PM – 5:10 PM The Neuro-Afib Study: Building the Foundation for Future Afib Research - Dr. Edip Gurol
5:10 PM – 5:30 PM Panel Discussion
Chair - Dr. Anil Saxena
Discussants - Dr. Jacqueline Saw and Dr. Jie Cheng
7:00 AM - 7:10 AM Cardio Neuro Team Approach and LAA Management - Dr. Moussa Mansour
7:10 AM – 7:20 AM How Do You Manage a Patient with GI Bleeding? – A Gastroenterologist Perspective - Dr. Neena Abraham
7:20 AM – 7:30 AM Sub-Clinical Atrial Fibrillation and Stroke Understanding the Connection - Dr. Andrea Russo
7:30 AM - 7:50 AM LIVE CASE
7:50 AM – 8:00 AM Dementia in AF - Impact of Ablation, LAAO and More - Dr. Andrea Natale
8:00 AM – 8:10 AM Is LA and LAA More Thrombogenic While In AF? - Evidence From the HEARTCLOT Study - Dr. Krzysztof Bartus
8:10 AM – 8:30 AM Debate: Lariat Followed by RFA Versus Convergent Followed By RFA - What Is a Better Treatment Option for Persistent AF? Dr. Randall Lee/Dr. Gansevoort Dunnington
8:30 AM - 8:50 AM Panel Discussion
8:50 AM - 9:10 AM Break
Chair - Dr. Saibal Kar
Discussants - Dr. Rakesh Gopinathannair and Dr. David Wilber
9:10 AM – 9:20 AM Ablating and Closing the LAA - Early Data From the Aurigen LAA Closure Device - Dr Dhanunjaya Lakkireddy
9:20 AM – 9:40 AM LIVE CASE
9:40 AM – 9:50 AM Anatomic Considerations For AtriClip and Post Procedural Management of AtriClip - Dr. Bart Maesen
9:50 AM – 10:10 AM AtriClip Recorded Case - Dr. Gansevoort Dunnington
10:10 AM – 10:20 AM When Should the Surgeons Eliminate LAA During Cardiac Operations - Dr. James Edgerton
10:20 AM – 10:40 AM Lambre Live/Recorded Case
10:40 AM – 11:00 AM WaveCrest Live/Recorded Case
11:00 AM – 11:20 AM Panel Discussion
Chair - Dr. Dhanunjaya Lakkireddy
Discussants - DR. Mohammad Alkhouli and Dr. Kan Fang
11:20 AM – 11:30 AM Amaze and Other New Lariat Trials Update - Dr. Abdi Rasekh
11:30 AM – 11:40 AM WATCHMAN Trials Update - Dr. David Holmes
11:40 AM – 11:50 AM Amulet & Abplatzen Cardiac Plug Trials Update - Amulet IDE & More - Dr. Apostolos Tzikas
11:50 AM – 12:00 AM AtriClip, LAAOS III, Convergent and More – Treating AF and LAA At the Same Time - Dr. Bart Maesen
12:00 PM – 12:20 PM Panel Discussion
12:20 PM – 1:00 PM Lunch
Chair - Dr. Luigi Di Base
Discussants - Dr. Srijoy Mahapatra and Dr. Walid Saliba
1:00 PM – 1:10 PM What Other Data Should Be Generated In the LAA Space? - Dr. Kan Fang
1:10 PM – 1:20 PM Design Enhancements Of the Next Generation LAAC Device: WATCHMAN FLX - Dr. Horst Sievert
1:20 PM – 1:30 PM Feasibility and Safety Of Same Day LAAO and TAVR/TMVR WATCHMAN-TAVR Study and More - Dr. Saibal Kar
1:30 PM – 1:40 PM Transitioning LAA Exclusion Technology From Clinical Trials To Market Place – Lessons From the Lariat, WATCHMAN and ACP Experience - Dr. Christopher Ellis
1:40 PM – 1:50 PM Shared Decision Making - Reducing Disparities In LAA Management - Dr. Megan Coylewright
1:50 PM – 2:00 PM Managing AF Patient With PFO Closure/ASD Role of Ablation, LAAO and PFO Closure Devices - Dr. Andrea Natale
2:00 PM – 2:20 PM Break
Chair - Christopher Ellis
Discussants - Dr. Apostolos Tzikas and Dr. Randall Lee
2:20 PM - 2:40 PM LIVE CASE
2:40 PM – 2:50 PM A Pathologist Perspective On The Future Of Stroke Prophylaxis, LAA Occluders and Tissue Specific Targets - Dr. Renu Virmani
2:50 PM – 3:00 PM NOACs Versus LAAO - PRAGUE 17, Catalyst, Champion and More - Dr. Vivek Reddy
3:00 PM – 3:10 PM Understanding NOACs In the 21st Century – Dual/Triple Therapy and Balancing AF and CAD - Dr. Shephal Doshi
3:10 PM – 3:20 PM My Patient Has an LAA Occluder and Had An Embolic CVA With No Evidence of Device Related Thrombus Or Carotid Disease – What Do I Do? - Dr. Luigi Di Biase
3:20 PM – 3:30 PM Can I Safely Cardiovert My Patient After An LAA Exclusion Procedure? When And How? Dr. Dhanunjaya Lakkireddy
3:30 PM – 3:40 PM Understanding LAA Closure Device Related Erosions, Pulmonary Vein and Mitral Valve Impingement and Delayed Effusions - Dr. Jacqueline Saw
3:40 PM – 3:50 PM Option Study - Background and Its Relevance To Clinical Practice - Dr. Oussama Wazni
3:50 PM – 4:10 PM Panel Discussion
Chair - Dr. Srinivas Dukkipati
Discussants - Dr. Andrea Natale and Dr. Vivek Reddy
4:10 PM – 5:20 PM My Most Challenging Cases - Dr. Devi Nair, Dr. Douglas Gibson, Dr. Alap Shah
5:20 PM. Adjourn/Remarks
ISLAA 2020
Date
February 7-8, 2020
(Friday to Saturday)
Venue
New York Marriott Marquis
1535 Broadway, New York, NY 10036